Stay up-to-date with the latest news, trends and developments in iPSCs.
Ncardia's Remarkable Journey in 2023: A Year of Growth, Innovation, and Leadership
Ncardia Welcomes Divisional CEO, Dr. Jeroen de Groot
Development of next generation of high-tech equipment for cell culture applications.
Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy Treatment
The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models
FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials